In Brief: Lasermedics
This article was originally published in The Gray Sheet
Executive Summary
Lasermedics: Acquires exclusive worldwide rights to manufacture, market and distribute CB Svendsen's MicroLight 830 low-level laser used for the treatment of Carpel Tunnel Syndrome. The laser is currently in U.S. clinical trials under an FDA investigational device exemption. Marketing and distribution rights were granted for a one-time payment and quarterly royalty payments based on sales over the next seven years, after which Lasermedics will have sole-ownership of the technology. Manufacturing rights were granted for a one-time payment due in June 1998. Under a separate agreement CB Svendsen will continue to manufacture the laser for Lasermedics for the international market...